Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> SHIRE PLC Latest News

APR 22, 2015 - TheStreet

A Must Read - Share

3 Large-Cap Pharmaceutical Companies to Invest in Right Now

NEW YORK (TheStreet) -- The pharmaceutical business can be risky. Drugs in development might not work; the Food and Drug Administration may not approve them; and even if it's approved, it could do poorly in the marketplace. Yet, pharmaceutical companies are protected by patents, and those patents allow them to recoup their research and development investments and then some should they ...

Tags: 3 Large-Cap Pharmaceutical Companies to Invest in Right Now,  Shire Plc Latest News

APR 10, 2015 - Zacks Investment Research

A Must Read - Share

Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog

Shire plc (SHPG) announced disappointing results from the phase II trial IMAGO on pipeline candidate SHP625 (formerly LUM001).

Tags: Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog,  Shire Plc Latest News

APR 08, 2015 - Zacks Investment Research

A Must Read - Share

Shire Reaches Agreement with the FDA for ADHD Candidate - Analyst Blog

Shire plc (SHPG) announced that it reached an agreement with the FDA on a clear regulatory path for its pipeline candidate SHP465.

Tags: Shire Reaches Agreement with the FDA for ADHD Candidate - Analyst Blog,  Shire Plc Latest News

APR 07, 2015 - Zacks Investment Research

A Must Read - Share

Shire's Lialda, Gattex Patents Challenged by Hayman Capital - Analyst Blog

Shire plc (SHPG) announced that two petitions have been filed with the U.S. Patent and Trademark Office (USPTO) on Apr 2 by Hayman Capital Management. The petitions are related to Shire's drugs Lialda and Gattex.

Tags: Shire's Lialda, Gattex Patents Challenged by Hayman Capital - Analyst Blog,  Shire Plc Latest News

APR 06, 2015 - Benzinga

A Must Read - Share

Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE

Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Shire plc (NASDAQ: SHPG) is 50.50%. Shire's PEG ratio is 1.01.

Tags: Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE,  Shire Plc Latest News